secwatch.observer — SEC 8-K summary
======================================

Issuer:     Assertio Holdings, Inc. (ASRT)
CIK:        0001808665
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001808665-25-000024
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio Q2 net product sales $28.8M, net loss $16.4M, cash rises to $98.2M
---------------------------------------------------------------------------

- GAAP net loss $16.4M ($0.17 per share) vs $3.7M loss ($0.04) in prior year Q2.
- Adjusted EBITDA $5.6M, up from $3.1M; adjusted EPS $0.02 vs $0.01.
- Rolvedon sales $16.1M (+$1M YoY); Sympazan $3.2M (+$0.5M); Indocin $3.0M (down from $6.9M due to generic competition).
- Cash & investments $98.2M, up from $87.3M at Q1 2025; company narrows guidance.
- SG&A $17.0M, down from $18.4M, includes $2.4M employee retention tax credit benefit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808665/000180866525000024/0001808665-25-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808665/000180866525000024/asrt-20250811.htm
  HTML page:      https://secwatch.observer/filing/0001808665-25-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer